Edgewise Therapeutics, Inc.

Historical 13F Holders

Symbol
EWTX
CUSIP
28036F105
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 220 105 M $2.32 B
2024 Q4 216 99.0 M $2.64 B
2024 Q3 193 102 M $2.71 B
2024 Q2 148 102 M $1.84 B
2024 Q1 135 92.4 M $1.69 B
2023 Q4 122 80.8 M $884 M
2023 Q3 88 68.4 M $392 M
2023 Q2 99 69.5 M $539 M
2023 Q1 88 66.5 M $443 M
2022 Q4 95 67.1 M $600 M
2022 Q3 97 65.9 M $649 M
2022 Q2 79 51.0 M $406 M
2022 Q1 74 54.0 M $524 M
2021 Q4 59 50.3 M $769 M
2021 Q3 49 48.0 M $796 M
2021 Q2 47 47.9 M $1.03 B
2021 Q1 32 45.7 M $1.48 B